
A federal grand jury returned an indictment against Dr. William Harwin, founder and former President of Florida Cancer Specialists & Research Institute (FCS), for conspiring to allocate medical and radiation oncology treatments for patients in Southwest Florida, the Department of Justice announced today.
The indictment, filed in the US District Court in Fort Myers, Florida, charges Harwin for participating in a criminal conspiracy with a competing oncology group in Collier, Lee, and Charlotte counties (Southwest Florida). Beginning as early as 1999, and continuing until at least 2016, Harwin and his co-conspirators entered into an illegal agreement to allocate medical oncology treatments, such as chemotherapy, to FCS and radiation oncology treatments to a competing oncology group. The conspiracy allowed FCS and the competing oncology group to operate with minimal competition in Southwest Florida and limited valuable integrated care options and choices for cancer patients.
“As the charge demonstrates, the division remains committed to holding culpable executives accountable for their crimes, especially when they impact vulnerable Americans, such as those in need of life-saving treatments,” said Assistant Attorney General Makan Delrahim of the Department of Justice’s Antitrust Division. “The Antitrust Division will continue to work to protect competition and integrity in the healthcare industry,” reported the DOJ in a press release.
“It is unconscionable for a doctor to prioritize profits over patient care,” said Michael F. McPherson, Special Agent in Charge of the FBI Tampa Field Office. “The FBI will persist in exposing unscrupulous medical providers who deny the public access to a competitive healthcare marketplace.”
Full Content: DOJ
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Top Australian Law Firms Target ACCC Talent Ahead of Major Merger Reforms
May 11, 2025 by
CPI
What the Google Antitrust Trial Has Revealed So Far
May 11, 2025 by
CPI
Hamlin Remains Confident in 23XI, Front Row Antitrust Case Against NASCAR
May 11, 2025 by
CPI
Google Faces €2.97 Billion Lawsuit in Italy Over Alleged Market Abuse
May 11, 2025 by
CPI
UFC Finalizes $375 Million Settlement in Fighter Antitrust Case
May 11, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Mergers in Digital Markets
Apr 21, 2025 by
CPI
Catching a Killer? Six “Genetic Markers” to Assess Nascent Competitor Acquisitions
Apr 21, 2025 by
John Taladay & Christine Ryu-Naya
Digital Decoded: Is There More Scope for Digital Mergers In 2025?
Apr 21, 2025 by
Colin Raftery, Michele Davis, Sarah Jensen & Martin Dickson
AI In the Mix – An Ever-Evolving Approach to Jurisdiction Over Digital Mergers in Europe
Apr 21, 2025 by
Ingrid Vandenborre & Ketevan Zukakishvili
Antitrust Enforcement Errors Due to a Failure to Understand Organizational Capabilities and Dynamic Competition
Apr 21, 2025 by
Magdalena Kuyterink & David J. Teece